Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/10/2019
SIETES contiene 92822 citas

 
 
 1 a 20 de 140 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626. [Ref.ID 97343]
2. Cita con resumen
Anónimo. Valvulopathies d'origine médicamenteuse. Prescrire 2013;33:668-72. [Ref.ID 96188]
3. Cita con resumen
Montastruc F, Montastruc G, Vigreux P, Bruneval P, Guilbeau-Frugier C, Cron C, Bagheri H, Delisle B, Lapeyre-Mestre M, Pathak A, Montastruc J-L. Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Br J Clin Pharmacol 2012;74:547-8. [Ref.ID 93709]
4. Cita con resumen
Seetohul LN, Maskell PD, De Paoli G, Pounder DJ. Designer drugs. Deaths associated with new designer drug 5-IT. BMJ 2012;345:22. [Ref.ID 93701]
5. Cita con resumen
Anónimo. Nearly 15,000 ED visits linked to patients being unwittingly drugged. DIA Daily 2011:11 de novembre. [Ref.ID 91606]
6. Cita con resumen
Anónimo. Ecstasy use does not reduce mental ability. BMJ 2011;342:406. [Ref.ID 90226]
7. Cita con resumen
Kuehn BM. Teen marijuana use on the rise. JAMA 2011;305:242. [Ref.ID 90088]
8. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
9.Tiene citas relacionadas
Álvarez Vara C. Éxtasis: un viejo éxito inquietante. Rev Clin Esp 2010;210:394-6. [Ref.ID 89055]
11. Cita con resumen
Dyer C. Scientists protest against proposals on advisory group membership. BMJ 2010;340:384. [Ref.ID 87888]
12. Cita con resumen
Gossop M, Hall W. Clashes between the government and its expert advisers. BMJ 2009;339:1095-6. [Ref.ID 87270]
13. Cita con resumen
Blakemore C. Classification of cannabis and ecstasy in the UK. BMJ 2009;338:490-1. [Ref.ID 85381]
14. Cita con resumen
Kmietowicz Z. UK government rejects advice from drugs adviser to downgrade ecstasy. BMJ 2009;338:435. [Ref.ID 85329]
17.Tiene citas relacionadas Cita con resumen
Nutt D, King L, Saulsbury W, Blakemore C. Assessing drug-related harm. Authors' reply. Lancet 2007;369:1857. [Ref.ID 80189]
18.Tiene citas relacionadas Cita con resumen
Murphy PN. Assessing drug-related harm. Lancet 2007;369:1856. [Ref.ID 80187]
19. Cita con resumen
Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med 2007;356:2064-72. [Ref.ID 80043]
20. Cita con resumen
McCarthy M. Prescription drug abuse up sharply in the USA. Lancet 2007;369:1505-6. [Ref.ID 79996]
Seleccionar todas
 
 1 a 20 de 140 siguiente >>